Faculty
Chapter I:
The Body of Evidence with SGLT-2 inhibitors in cardio-renal risk reduction
Cardiovascular Outcomes Trials with SGLT-2 inhibitors
SGLT-2 Inhibitors and Heart Failure
SGLT-2 Inhibitors and Chronic Kidney Disease
Current Guidelines and Recommendations
Conclusions
Chapter II:
Translating the Evidence: Patient Cases
Case 1
Case 2
Chapter III:
Clinical Pearls
Chapter IV:
Additional Resources for Healthcare Providers
Chapter V:
News Digest
Article Submission
References
What is the first letter of the alphabet
ab
bc
cd
de
Please write some text !
Add Option
Submit
Results
